Incyte at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Incyte brings 8 presentations to ASH 2026 in New Orleans, and exhibits at Booth 228, 1113. Incyte presents sponsored sessions on myelofibrosis, polycythemia and lymphoma treatment. It also hosts a theater talk on follicular lymphoma and brings research on tafasitamab and a new CALR-targeting antibody.
| Organization | ASH 2026 Attendance |
|---|---|
Incyte Wilmington, DE | |
Biopharmaceutical company discovering, developing and marketing its own medicines in oncology and in inflammation and autoimmunity. | Booth Exhibiting at Booth 228, 1113 Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm Symposium Fri Dec 11 3:00pm–6:00pm A Case-Based Exploration of Current and Future Directions in Myelofibrosis – Where We Are, Where We’re Going Real patient cases showing how experts treat myelofibrosis today, paired with reviews of current data and ongoing research on emerging therapies. Symposium Fri Dec 11 7:00pm–10:00pm Addressing Community Oncologists’ Questions About Novel Therapies in Non-Hodgkin Lymphoma – What Clinicians Want To Know Answers to community oncologists' most pressing questions about new drugs for non-Hodgkin lymphoma, drawn from a survey and reviewed against current research. Talk Sun Dec 13 11:30am–12:30pm Oral Sun Dec 13 4:30pm–6:00pm Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm |
Find decision makers at Incyte
Tell us what you sell and we’ll find the people at Incyte most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction